Teva appears to have stopped efforts on its ALK inhibitor

Teva appears to be scaling back efforts in most of its cancer research.

Here is a link to an article.

http://www.pmlive.com/pharma_news/teva_scales_back_r_and_d_as_copaxone_competition_looms_604284

This entry was posted in CEP-37440, Lung cancer, Research. Bookmark the permalink.

Leave a Reply